Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy
The Parkinson’s Institute and Clinical Center and Retrotope are teaming up to study a potential new therapy for patients with progressive supranuclear palsy. For more information about this collaboration, you…